rs11280056

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

The NM_017512.7(ENOSF1):​c.*856_*861delCTTTAA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.383 in 217,316 control chromosomes in the GnomAD database, including 17,511 homozygotes. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 12782 hom., cov: 0)
Exomes 𝑓: 0.36 ( 4729 hom. )

Consequence

ENOSF1
NM_017512.7 3_prime_UTR

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.42

Publications

33 publications found
Variant links:
Genes affected
ENOSF1 (HGNC:30365): (enolase superfamily member 1) This gene can encode a mitochondrial enzyme that is thought to convert L-fuconate to 2-keto-3-deoxy-L-fuconate. This locus was originally identified as the source of antisense RNAs of the adjacent thymidylate synthase gene. Splice variants at this locus may contain an alternate 3' exon that is complementary to the 3'UTR and terminal intron of the thymidylate synthase (TS) RNA and may downregulate TS expression. [provided by RefSeq, Aug 2017]
TYMS (HGNC:12441): (thymidylate synthetase) Thymidylate synthase catalyzes the methylation of deoxyuridylate to deoxythymidylate using, 10-methylenetetrahydrofolate (methylene-THF) as a cofactor. This function maintains the dTMP (thymidine-5-prime monophosphate) pool critical for DNA replication and repair. The enzyme has been of interest as a target for cancer chemotherapeutic agents. It is considered to be the primary site of action for 5-fluorouracil, 5-fluoro-2-prime-deoxyuridine, and some folate analogs. Expression of this gene and that of a naturally occurring antisense transcript, mitochondrial enolase superfamily member 1 (GeneID:55556), vary inversely when cell-growth progresses from late-log to plateau phase. Polymorphisms in this gene may be associated with etiology of neoplasia, including breast cancer, and response to chemotherapy. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.661 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ENOSF1NM_017512.7 linkc.*856_*861delCTTTAA 3_prime_UTR_variant Exon 16 of 16 ENST00000647584.2 NP_059982.2 Q7L5Y1-1
TYMSNM_001071.4 linkc.*450_*455delAAGTTA 3_prime_UTR_variant Exon 7 of 7 ENST00000323274.15 NP_001062.1 P04818-1Q53Y97

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENOSF1ENST00000647584.2 linkc.*856_*861delCTTTAA 3_prime_UTR_variant Exon 16 of 16 NM_017512.7 ENSP00000497230.2 Q7L5Y1-1
TYMSENST00000323274.15 linkc.*450_*455delAAGTTA 3_prime_UTR_variant Exon 7 of 7 1 NM_001071.4 ENSP00000315644.10 P04818-1

Frequencies

GnomAD3 genomes
AF:
0.395
AC:
59744
AN:
151380
Hom.:
12769
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.547
Gnomad AMI
AF:
0.165
Gnomad AMR
AF:
0.333
Gnomad ASJ
AF:
0.398
Gnomad EAS
AF:
0.680
Gnomad SAS
AF:
0.448
Gnomad FIN
AF:
0.301
Gnomad MID
AF:
0.471
Gnomad NFE
AF:
0.308
Gnomad OTH
AF:
0.396
GnomAD4 exome
AF:
0.358
AC:
23543
AN:
65816
Hom.:
4729
AF XY:
0.354
AC XY:
10768
AN XY:
30388
show subpopulations
African (AFR)
AF:
0.525
AC:
1508
AN:
2874
American (AMR)
AF:
0.289
AC:
672
AN:
2322
Ashkenazi Jewish (ASJ)
AF:
0.361
AC:
1483
AN:
4106
East Asian (EAS)
AF:
0.633
AC:
5735
AN:
9064
South Asian (SAS)
AF:
0.416
AC:
266
AN:
640
European-Finnish (FIN)
AF:
0.250
AC:
14
AN:
56
Middle Eastern (MID)
AF:
0.458
AC:
176
AN:
384
European-Non Finnish (NFE)
AF:
0.290
AC:
11891
AN:
41016
Other (OTH)
AF:
0.336
AC:
1798
AN:
5354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.449
Heterozygous variant carriers
0
534
1068
1602
2136
2670
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.395
AC:
59790
AN:
151500
Hom.:
12782
Cov.:
0
AF XY:
0.398
AC XY:
29482
AN XY:
74028
show subpopulations
African (AFR)
AF:
0.547
AC:
22575
AN:
41276
American (AMR)
AF:
0.333
AC:
5077
AN:
15236
Ashkenazi Jewish (ASJ)
AF:
0.398
AC:
1379
AN:
3466
East Asian (EAS)
AF:
0.680
AC:
3461
AN:
5090
South Asian (SAS)
AF:
0.445
AC:
2139
AN:
4804
European-Finnish (FIN)
AF:
0.301
AC:
3168
AN:
10532
Middle Eastern (MID)
AF:
0.469
AC:
137
AN:
292
European-Non Finnish (NFE)
AF:
0.308
AC:
20869
AN:
67798
Other (OTH)
AF:
0.398
AC:
835
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1723
3447
5170
6894
8617
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
562
1124
1686
2248
2810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.346
Hom.:
1165
Bravo
AF:
0.406
Asia WGS
AF:
0.574
AC:
1997
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11280056; hg19: chr18-673443; COSMIC: COSV51891993; COSMIC: COSV51891993; API